A lawsuit filed by six women claim the recalled BioZorb implant was defectively designed, causing pain, infections, swelling and fears of a return of their breast cancer.
A federal judge has ordered plaintiffs and defendants involved in hair relaxer cancer litigation to select 20 cases each, for a total of 40, to undergo case-specific discovery to prepare them to serve as potential bellwether trials.
A federal judge has approved the direct filing of AngioDynamics port catheter lawsuits in the U.S. District Court for the District of Southern California, where the litigation has been centralized for coordinated discovery and pretrial proceedings.
